Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Gastric Cancer

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 5 articles:
HTML format

Single Articles

    December 2023
  1. SMYTH EC, Sundar R
    Combining chemotherapy, trastuzumab, and immune-checkpoint inhibitors in HER2-positive gastro-oesophageal cancer.
    Lancet. 2023;402:2168-2170.

    May 2023
  2. SHITARA K, Lordick F, Bang YJ, Enzinger P, et al
    Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 tr
    Lancet. 2023;401:1655-1668.
    PubMed     Abstract available

    March 2023
  3. O'MAHONY D, Power SP, Power DG
    Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab.
    Lancet. 2023;401:772.

    July 2021
  4. JANJIGIAN YY, Shitara K, Moehler M, Garrido M, et al
    First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
    Lancet. 2021;398:27-40.
    PubMed     Abstract available

    January 2021

  5. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries.
    Lancet. 2021;397:387-397.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.